Journal of Nanobiotechnology | |
Ceria nanoparticles ameliorate renal fibrosis by modulating the balance between oxidative phosphorylation and aerobic glycolysis | |
Feng Zeng1  Yinhang Wang2  Hong Xin2  Xudong Xu2  Fengling Ning2  Dongliang Zhang2  Shilin Zhou2  Cong Li2  Jiaqi He2  Xiaolin Sun2  Mengling Wang2  Ping Hu2  Xuemei Zhang2  Svetlana Reilly3  Cong Wang4  Jisheng Xiao5  | |
[1] Artemisinin Research Center, Institute of Science and Technology, The First Clinical Medical School, Lingnan Medical Research Center, The First Affiliated Hospital, Guangzhou University of Chinese Medicine, 510405, Guangzhou, China;Department of Pharmacology, School of Pharmacy, Minhang Hospital, Fudan University, 201203, Shanghai, China;Division of Cardiovascular Medicine, Department of Medicine, University of Oxford, John Radcliffe Hospital, RadcliffeOxford, UK;Key Laboratory of Smart Drug Delivery, Ministry of Education, School of Pharmacy, Fudan University, Shanghai, China, Academy for Engineering and Technology, Fudan University, 20 Handan Road, Yangpu District, 200433, Shanghai, China;Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, 510405, Guangzhou, China; | |
关键词: Ceria nanoparticles; Metabolic reprogramming; Oxidative phosphorylation; Aerobic glycolysis; Renal fibrosis; | |
DOI : 10.1186/s12951-021-01122-w | |
来源: Springer | |
【 摘 要 】
Background and aimsRenal fibrosis is the common outcome in all progressive forms of chronic kidney disease. Unfortunately, the pathogenesis of renal fibrosis remains largely unexplored, among which metabolic reprogramming plays an extremely crucial role in the evolution of renal fibrosis. Ceria nanoparticles (CeNP-PEG) with strong ROS scavenging and anti-inflammatory activities have been applied for mitochondrial oxidative stress and inflammatory diseases. The present study aims to determine whether CeNP-PEG has therapeutic value for renal fibrosis.MethodsThe unilateral ureteral obstructive fibrosis model was used to assess the therapeutic effects in vivo. Transforming growth factor beta1-induced epithelial-to-mesenchymal transition in HK-2 cells was used as the in vitro cell model. The seahorse bioscience X96 extracellular flux analyzer was used to measure the oxygen consumption rate and extracellular acidification rate.ResultsIn the present study, CeNP-PEG treatment significantly ameliorated renal fibrosis by increased E-cadherin protein expression, and decreased α-SMA, Vimentin and Fibronectin expression both in vitro and in vivo. Additionally, CeNP-PEG significantly reduced the ROS formation and improved the levels of mitochondrial ATP. The seahorse analyzer assay demonstrated that the extracellular acidification rate markedly decreased, whereas the oxygen consumption rate markedly increased, in the presence of CeNP-PEG. Furthermore, the mitochondrial membrane potential markedly enhanced, hexokinase 1 and hexokinase 2 expression significantly decreased after treatment with CeNP-PEG.ConclusionsCeNP-PEG can block the dysregulated metabolic status and exert protective function on renal fibrosis. This may provide another therapeutic option for renal fibrosis.Graphical Abstract
【 授权许可】
CC BY
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202203111704423ZK.pdf | 3068KB | download |